Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late NIPS to Guide Subsequent VT Therapeutic Strategies
NCT06669299Recruiting
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jun 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in ventricular tachycardia (VT) (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Ventricular Tachycardia recurrence free survival rate at 12 months. Started Jun 2025; status: recruiting.
02
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT06669299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06669299.